Maintenance treatment for gastro-oesophageal reflux disease - A placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice

Gastro-oesophageal reflux disease (CORD) is a frequent cause for consultation in general practice and is a chronically relapsing disease. Methods: This general practice study was a 6-month randomized, double-blind parallel-group placebo-controlled assessment of the efficacy and safety of continuous treatment with 10 mg omeprazole every morning after initial symptom control in 495 patients with GORD but without erosive oesophagitis. Results: On the basis of life-table estimates for cumulative relapse rates, patients in the placebo group (52%) were almost twice as likely as those in the omeprazole group (27%) to discontinue therapy before 24 weeks because of inadequate relief of heartburn or for other reasons including adverse events (all-patients-treated analysis, log rank test, P=0.0001). Conclusions: This study has shown that 10 mg omeprazole once daily is an effective and well-tolerated treatment strategy in general practice for the long-term management of symptoms of GORD in patients without erosive oesophagitis.